AMS Fundamental Analysis - AMERICAN SHARED HOSPITAL SER

Fundamental Rating

AMS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While AMS is still in line with the averages on profitability rating, there are concerns on its financial health. AMS has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AMS has reported negative net income.

In the past year AMS had a positive cash flow from operations.

Of the past 5 years AMS 4 years were profitable.

In the past 5 years AMS always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 2.28%, AMS is in the better half of the industry, outperforming 60.40% of the companies in the same industry.

AMS has a better Return On Equity (5.85%) than 63.37% of its industry peers.

Looking at the Return On Invested Capital, with a value of 0.97%, AMS is in line with its industry, outperforming 41.58% of the companies in the same industry.

AMS had an Average Return On Invested Capital over the past 3 years of 4.67%. This is below the industry average of 9.19%.

		Industry Rank	Sector Rank
ROA	2.28%
ROE	5.85%
ROIC	0.97%

ROA(3y)2.64%

ROA(5y)-1.57%

ROE(3y)5.84%

ROE(5y)-3.63%

ROIC(3y)4.67%

ROIC(5y)N/A

1.3 Margins

With a decent Profit Margin value of 4.93%, AMS is doing good in the industry, outperforming 77.23% of the companies in the same industry.

In the last couple of years the Profit Margin of AMS has grown nicely.

AMS has a Operating Margin of 2.22%. This is comparable to the rest of the industry: AMS outperforms 51.49% of its industry peers.

AMS's Operating Margin has declined in the last couple of years.

AMS has a Gross Margin of 27.31%. This is comparable to the rest of the industry: AMS outperforms 54.46% of its industry peers.

AMS's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	2.22%
PM (TTM)	4.93%
GM	27.31%

OM growth 3Y-20.48%

OM growth 5Y-14.68%

PM growth 3Y92.72%

PM growth 5Y19.22%

GM growth 3Y-5.31%

GM growth 5Y-0.7%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMS is destroying value.

AMS has more shares outstanding than it did 1 year ago.

AMS has more shares outstanding than it did 5 years ago.

AMS has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that AMS is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of AMS (1.06) is worse than 68.32% of its industry peers.

AMS has a Debt/Equity ratio of 0.76. This is a neutral value indicating AMS is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.76, AMS is in line with its industry, outperforming 45.54% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.76
Debt/FCF	N/A
Altman-Z	1.06

ROIC/WACC0.11

WACC9.25%

2.3 Liquidity

AMS has a Current Ratio of 1.87. This is a normal value and indicates that AMS is financially healthy and should not expect problems in meeting its short term obligations.

AMS's Current ratio of 1.87 is fine compared to the rest of the industry. AMS outperforms 69.31% of its industry peers.

AMS has a Quick Ratio of 1.87. This is a normal value and indicates that AMS is financially healthy and should not expect problems in meeting its short term obligations.

AMS's Quick ratio of 1.87 is fine compared to the rest of the industry. AMS outperforms 72.28% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.87
Quick Ratio	1.87

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for AMS have decreased strongly by -511.11% in the last year.

Measured over the past years, AMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.28% on average per year.

The Revenue has grown by 32.90% in the past year. This is a very strong growth!

Measured over the past years, AMS shows a small growth in Revenue. The Revenue has been growing by 6.58% on average per year.

EPS 1Y (TTM)-511.11%

EPS 3Y121.52%

EPS 5Y24.28%

EPS Q2Q%-300%

Revenue 1Y (TTM)32.9%

Revenue growth 3Y17.14%

Revenue growth 5Y6.58%

Sales Q2Q%0.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y49.5%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year9.31%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMS. In the last year negative earnings were reported.

Also next year AMS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMS indicates a rather cheap valuation: AMS is cheaper than 98.02% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	3.51

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AMS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AMERICAN SHARED HOSPITAL SER

NYSEARCA:AMS (9/17/2025, 8:23:07 PM)

After market: 2.52 +0.11 (+4.56%)

2.41

+0.01 (+0.37%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)08-13 2025-08-13/bmo

Earnings (Next)11-11 2025-11-11

Inst Owners13.91%

Inst Owner Change-4.84%

Ins Owners34.16%

Ins Owner Change4.75%

Market Cap15.69M

Analysts80

Price Target4.59 (90.46%)

Short Float %1.58%

Short Ratio11.6

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-1039.6%

Min EPS beat(2)-2080.2%

Max EPS beat(2)0.99%

EPS beat(4)1

Avg EPS beat(4)-582.62%

Min EPS beat(4)-2080.2%

Max EPS beat(4)0.99%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)7.83%

Min Revenue beat(2)-0.96%

Max Revenue beat(2)16.61%

Revenue beat(4)2

Avg Revenue beat(4)5.32%

Min Revenue beat(4)-7.97%

Max Revenue beat(4)16.61%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-7.22%

PT rev (3m)-7.22%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)-173.33%

EPS NY rev (3m)-173.33%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)-4.44%

Revenue NY rev (3m)-15.02%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.54
P/FCF	N/A
P/OCF	3.46
P/B	0.64
P/tB	0.67
EV/EBITDA	3.51

EPS(TTM)-0.37

EYN/A

EPS(NY)-0.11

Fwd EYN/A

FCF(TTM)-0.96

FCFYN/A

OCF(TTM)0.7

OCFY28.91%

SpS4.49

BVpS3.79

TBVpS3.58

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	2.28%
ROE	5.85%
ROCE	1.28%
ROIC	0.97%
ROICexc	1.24%
ROICexgc	1.28%
OM	2.22%
PM (TTM)	4.93%
GM	27.31%
FCFM	N/A

ROA(3y)2.64%

ROA(5y)-1.57%

ROE(3y)5.84%

ROE(5y)-3.63%

ROIC(3y)4.67%

ROIC(5y)N/A

ROICexc(3y)6.77%

ROICexc(5y)N/A

ROICexgc(3y)7.11%

ROICexgc(5y)N/A

ROCE(3y)6.05%

ROCE(5y)N/A

ROICexcg growth 3Y-13.43%

ROICexcg growth 5Y-5.81%

ROICexc growth 3Y-13.18%

ROICexc growth 5Y-6.48%

OM growth 3Y-20.48%

OM growth 5Y-14.68%

PM growth 3Y92.72%

PM growth 5Y19.22%

GM growth 3Y-5.31%

GM growth 5Y-0.7%

F-Score5

Asset Turnover0.46

Health

		Industry Rank	Sector Rank
Debt/Equity	0.76
Debt/FCF	N/A
Debt/EBITDA	2.71
Cap/Depr	171.25%
Cap/Sales	36.84%
Interest Coverage	0.43
Cash Conversion	65.37%
Profit Quality	N/A
Current Ratio	1.87
Quick Ratio	1.87
Altman-Z	1.06

F-Score5

WACC9.25%

ROIC/WACC0.11

Cap/Depr(3y)86.06%

Cap/Depr(5y)59.68%

Cap/Sales(3y)19.8%

Cap/Sales(5y)14.29%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-511.11%

EPS 3Y121.52%

EPS 5Y24.28%

EPS Q2Q%-300%

EPS Next Y49.5%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)32.9%

Revenue growth 3Y17.14%

Revenue growth 5Y6.58%

Sales Q2Q%0.21%

Revenue Next Year9.31%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-70.81%

EBIT growth 3Y-6.85%

EBIT growth 5Y-9.07%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-175.94%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-48.11%

OCF growth 3Y-70.14%

OCF growth 5Y-53.93%

AMERICAN SHARED HOSPITAL SER (AMS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens